课题基金 / 基金详情

Project 5 - Genetic architecture of alcohol use disorder using cross-trait genetic correlations and public next-generation sequencing studies

Project 5 - Genetic architecture of alcohol use disorder using cross-trait genetic correlations and public next-generation sequencing studies
项目 5 - 使用跨性状遗传相关性和公共下一代测序研究的酒精使用障碍的遗传结构
批准号:
10633321
负责人:
BRADLEY Todd WEBB
金额:
$18.67万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
未结题
起止时间:
2014-08-05 至 2025-05-31

项目摘要

项目成果

BRADLEY Todd WEBB的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary – Project 5 Recent advances in the study of human complex traits include 1) a growing catalog of robustly associated common variants found using genome-wide association studies (GWAS), 2) the ability to assess the contribution of rare variation through genome sequencing studies of both whole exomes (WES) and genomes (WGS), and 3) wide-spread cross-trait genetic correlation. For alcohol use disorder (AUD) and related phenotypes, there is an opportunity to discover novel rare variation and understand the overall pattern of evidence across the allele frequency spectrum including common and rare variation. One lesson from GWAS is that most robust associations do not create protein coding changes and some robust genome-wide significant variation does not reside in genes at all. As WES expands to include untranslated regions (UTRs) and WGS becomes affordable, there is a significant challenge in analyzing the variation that does not impact protein coding directly. Fortunately, there is a growing catalog of functional elements across the genome that can be interrogated to determine which harbor variants influencing AUD. For sequencing based analyses of rare variation, these functional elements showing enrichment can be leveraged to improve detection. As more variants associated with AUD are discovered and the catalog of traits with genetic correlations grows, determining how specific these variants are to AUD becomes more important. For example, do discovered loci influence a) addiction in general, b) alcohol consumption, or c) AUD specifically or do they non-specifically influence many physical or mental health outcomes. In addition to determining if loci, in aggregate or individually, can be considered primary or secondary AUD risk loci, understanding the direction of causation across traits and time is critically important to identifying opportunities for intervention. One powerful approach to investigate causative relationships is through Mendelian Randomization analysis. The overall goal of this project is to leverage existing twin, family, epidemiological, and molecular data in novel ways to a) discover loci harboring rare variants that influencing AUD without new molecular data generation, b) differentiate loci that influence common versus specific AUD liability factors, and c) understand the architecture of AUD using an integrated and iterative approach.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Adapting machine learning methods to detect genetic loci specific to strictly defined MDD
  • 批准号:
    10196078
  • 项目类别:
  • 资助金额:
    $20.84万
  • 财政年份:
    2021
  • 负责人:
    BRADLEY Todd WEBB
  • 依托单位:
Adapting machine learning methods to detect genetic loci specific to strictly defined MDD
  • 批准号:
    10378100
  • 项目类别:
  • 资助金额:
    $20.84万
  • 财政年份:
    2021
  • 负责人:
    BRADLEY Todd WEBB
  • 依托单位:
Project 5 - Genetic architecture of alcohol use disorder using cross-trait genetic correlations and public next-generation sequencing studies
  • 批准号:
    10429957
  • 项目类别:
  • 资助金额:
    $18.78万
  • 财政年份:
    2014
  • 负责人:
    BRADLEY Todd WEBB
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: